Palmoplantar psoriasis: A clinico-epidemiological study with special reference to its impact on quality of life
DOI:
https://doi.org/10.66344/jpad.v34i1.2765Keywords:
Palmoplantar psoriasis, Quality of life, Eastern IndiaAbstract
Background Palmoplantar psoriasis (PPP) is a variety of psoriasis constituting 3-4% of psoriatic and mainly affects the skin of the palms and soles. It is often a disfiguring disease and exerts a considerable negative intact on the quality of life (QoL) of the involved. Only few studies have evaluated QoL in PPP, especially in eastern India.
Objective We aimed to study the demographic profile of patients with PPP, clinical characteristics and quantify the impact of the disease on the QoL of patients.
Methods Eligible patients were evaluated with history, clinical examination and quality of life assessment by two separate instruments, namely QoL assessment introduced by Farley et al. and Dermatology Life Quality Index by Finley. The findings of each patient were noted on separate case record sheets.
Results One hundred patients were studied. Age of the patients ranged from14-65 years. Most patients (51%) had psoriatic involvement of other body areas in addition to palms and soles. 5% patients had family history of psoriasis. This study supports the impression that even with limited body surface involvement; patients with PPP suffer from a significant impact as measured on both instruments. There was significant correlation between the measures of quality of life between the two instruments and inverse correlation with involved surface area of body involvement.
Conclusion Palmoplantar psoriasis (PPP) affects both genders almost equally, affecting our population almost a decade earlier than our western counterparts. PPP causes significant decrease in overall Quality of Life other than causing social embarrassment.
References
1. Dogra S, Yadav S. Psoriasis in India: prevalence and pattern. Indian J Dermatol Venereol Leprol. 2010;76(6):595-601.
2. Kimball AB, Jacobson C, Weiss S, Vreeland MG, Wu Y. The psychosocial burden of psoriasis. Am J Clin Dermatol. 2005;6:383-92.
3. deArruda LH, De Moraes AP. The impact of psoriasis on quality of life. Br J Dermatol. 2001;Suppl 58:33-6.
4. Kumar B, Saraswat A, Kaur I. Palmoplantar lesions in psoriasis: a study of 3065 patients. Acta DermVenereol. 2002;82(3):192-5.
5. Raposo I, Torres T. Palmoplantar Psoriasis and Palmoplantar Pustulosis: Current Treatment and Future Prospects. Am J Clin Dermatol. 2016;17:349-58.
6. Farley E, Masrour S, McKey J, Menter A. Palmoplantar psoriasis: a phenotypical and clinical review with introduction of a new quality-of-life assessment tool. J Am Acad Dermatol. 2009;60:1024-31.
7. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19:210-6.
8. Chung J, Duffin K C, Takeshita J. et al. Palmoplantar psoriasis is associated with greater impairment of health-related quality of life compared with moderate to severe plaque psoriasis. J Am Acad Dermatol. 2014;04:063.
9. Pettey AA, Balkrishnan R, Rapp SR et al. Patients with palmoplantar psoriasis have more physical disability and discomfort than patients with other forms of psoriasis: implications for clinical practice. J Am Acad Dermatol. 2003;49:271–5.
10. Khandpur S, Singhal V, Sharma VK. Palmoplantar involvement in psoriasis: a clinical study. Indian J Dermatol Venereol Leprol. 2011;77:625.
11. Chopra A, Maninder, Gill SS. Hyperkeratosis of palms and soles: Clinical study. Indian J Dermatol Venereol Leprol. 1997;63:85-8.
12. Smoking Rates by Country 2022. From: https://worldpopulationreview.com/country-rankings/smoking-rates-by-country. [last accessed on 05.05.2023].
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Ismat Ara Khan, Loknath Ghoshal, Karunamoy Chakraborty, Debabrata Bandyopadhyay
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
